Evolution of DNA methylation is linked to genetic aberrations in chronic lymphocytic leukemia

Cancer Discovery

Volumn 4, Issue 3, 2014, Pages 348-361

  Oakes, Christopher C ^a   Claus, Rainer ^a,e   Gu, Lei ^a   Assenov, Yassen ^a   Hüllein, Jennifer ^c   Zucknick, Manuela ^a   Bieg, Matthias ^a   Brocks, David ^a   Bogatyrova, Olga ^a   Schmidt, Christopher R ^a   Rassenti, Laura ^g   Kipps, Thomas J ^g   Mertens, Daniel ^b,f   Lichter, Peter ^a,b   Döhner, Hartmut ^f   Stilgen, Stephan ^f   Byrd, John C ^h   Zenz, Thorsten ^c,d   Plass, Christoph ^a  

^a Divisions of Epigenomics and Cancer Risk Factors ^*  (Germany)

^b Divisions of Molecular Genetics   (United States)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e UNIVERSITY OF FREIBURG   (Germany)

^f UNIVERSITY OF ULM   (Germany)

^g UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^h OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; ARTICLE; CANCER PROGNOSIS; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; COPY NUMBER VARIATION; CYTOGENETICS; DNA METHYLATION; EPIGENETICS; FLUORESCENCE IN SITU HYBRIDIZATION; GENE MUTATION; GENETIC HETEROGENEITY; GENETIC MARKER; GLIOBLASTOMA; HUMAN; HUMAN CELL; LYMPHOCYTE; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PREDICTION; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; CHROMOSOMES, HUMAN; CPG ISLANDS; DISEASE PROGRESSION; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION REGULATION, LEUKEMIC; GENETIC HETEROGENEITY; GENOME, HUMAN; GENOMIC INSTABILITY; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MIDDLE AGED;

EID: 84895783051     PISSN: 21598274     EISSN: 21598290     Source Type: Journal    
DOI: 10.1158/2159-8290.CD-13-0349     Document Type: Article

References (44)

1. Baylin SB, Jones PA. A decade of exploring the cancer epigenome- biological and translational implications. Nat Rev Cancer 2011;11: 726-734.
2. Broske AM, Vockentanz L, Kharazi S, Huska MR, Mancini E, Scheller M, et al. DNA methylation protects hematopoietic stem cell multipo-tency from myeloerythroid restriction. Nat Genet 2009;41:1207-1215.
3. Trowbridge JJ, Snow JW, Kim J, Orkin SH. DNA methyltransferase 1 is essential for and uniquely regulates hematopoietic stem and progenitor cells. Cell Stem Cell 2009; 5: 442-449.
4. Timp W, Feinberg AP. Cancer as a dysregulated epigenome allowing cellular growth advantage at the expense of the host. Nat Rev Cancer 2013;13:497-510.
5. Gerlinger M, Rowan AJ, Horswell S, Larkin J, Endesfelder D, Gronroos E, et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 2012; 366: 883-892.
6. Nik-Zainal S, Van Loo P, Wedge DC, Alexandrov LB, Greenman CD, Lau KW, et al. The life history of 21 breast cancers. Cell 2012;149:994-1007.
7. Navin N, Kendall J, Troge J, Andrews P, Rodgers L, McIndoo J, et al. Tumour evolution inferred by single-cell sequencing. Nature 2011;472:90-94.
8. Mullighan CG, Phillips LA, Su X, Ma J, Miller CB, Shurtleff SA, et al. Genomic analysis of the clonal origins of relapsed acute lymphoblas-tic leukemia. Science 2008;322:1377-1380.
9. Ding L, Ley TJ, Larson DE, Miller CA, Koboldt DC, Welch JS, et al. Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. Nature 2012;481:506-510.
10. Schuh A, Becq J, Humphray S, Alexa A, Burns A, Clifford R, et al. Monitoring chronic lymphocytic leukemia progression by whole genome sequencing reveals heterogeneous clonal evolution patterns. Blood 2012;120:4191-4196.
11. Landau DA, Carter SL, Stojanov P, McKenna A, Stevenson K, Lawrence MS, et al. Evolution and impact of subclonal mutations in chronic lymphocytic leukemia. Cell 2013;152:714-726.
12. Cahill N, Bergh AC, Kanduri M, Goransson-Kultima H, Mansouri L, Isaksson A, et al. 450K-array analysis of chronic lymphocytic leukemia cells reveals global DNA methylation to be relatively stable over time and similar in resting and proliferative compartments. Leukemia 2013;27:150-158.
13. Stilgenbauer S, Sander S, Bullinger L, Benner A, Leupolt E, Winkler D, et al. Clonal evolution in chronic lymphocytic leukemia: acquisition of high-risk genomic aberrations associated with unmutated VH, resistance to therapy, and short survival. Haematologica 2007; 92:1242-1245.
14. Hansen KD, Timp W, Bravo HC, Sabunciyan S, Langmead B, McDonald OG, et al. Increased methylation variation in epigenetic domains across cancer types. Nat Genet 2011;43:768-775.
15. Landan G, Cohen NM, Mukamel Z, Bar A, Molchadsky A, Brosh R, et al. Epigenetic polymorphism and the stochastic formation of differentially methylated regions in normal and cancerous tissues. Nat Genet 2012;44:1207-1214.
16. Rush LJ, Raval A, Funchain P, Johnson AJ, Smith L, Lucas DM, et al. Epigenetic profi ling in chronic lymphocytic leukemia reveals novel methylation targets. Cancer Res 2004;64:2424-2433.
17. Kulis M, Heath S, Bibikova M, Queiros AC, Navarro A, Clot G, et al. Epigenomic analysis detects widespread gene-body DNA hypometh-ylation in chronic lymphocytic leukemia. Nat Genet 2012; 44: 1236-1242.
18. Kanduri M, Cahill N, Goransson H, Enström C, Isaksson A, Rosen-quist R. Differential genome-wide array-based methylation pro-fi les in prognostic subsets of chronic lymphocytic leukemia. Blood 2010;115:296-305.
19. Claus R, Lucas DM, Stilgenbauer S, Ruppert AS, Yu LB, Zucknick M, et al. Quantitative DNA methylation analysis identifi es a single CpG dinucleotide important for ZAP-70 expression and predictive of prognosis in chronic lymphocytic leukemia. J Clin Oncol 2012; 30: 2483-2491.
20. Ehrlich M, Lacey M. DNA hypomethylation and hemimethylation in cancer. Adv Exp Med Biol 2013;754:31-56.
21. Hon GC, Hawkins RD, Caballero OL, Lo C, Lister R, Pelizzola M, et al. Global DNA hypomethylation coupled to repressive chromatin domain formation and gene silencing in breast cancer. Genome Res 2012;22:246-258.
22. Fang F, Hodges E, Molaro A, Dean M, Hannon GJ, Smith AD. Genomic landscape of human allele-specifi c DNA methylation. Proc Natl Acad Sci U S A 2012;109:7332-7337.
23. Xie W, Barr CL, Kim A, Yue F, Lee AY, Eubanks J, et al. Base-resolution analyses of sequence and parent-of-origin dependent DNA methyla-tion in the mouse genome. Cell 2012;148:816-831.
24. Sturm D, Witt H, Hovestadt V, Khuong-Quang DA, Jones DTW, Konermann C, et al. Hotspot mutations in H3F3A and IDH1 defi ne distinct epigenetic and biological subgroups of glioblastoma. Cancer Cell 2012;22:425-437.
25. Network CGAR. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med 2013;368:2059-2074.
26. TCGA. The Cancer Genome Atlas Data Portal. 2013. Available from: https://tcga-data.nci.nih.gov/tcga/tcgaHome2.jsp. Accessed February 1, 2013.
27. Muzny DM, Bainbridge MN, Chang K, Dinh HH, Drummond JA, Fowler G, et al. Comprehensive molecular characterization of human colon and rectal cancer. Nature 2012;487:330-337.
28. De S, Shaknovich R, Riester M, Elemento O, Geng HM, Kormaks-son M, et al. Aberration in DNA methylation in B-cell lymphomas has a complex origin and increases with disease severity. PLoS Genet 2013;9:e1003137.
29. Ji H, Ehrlich LIR, Seita J, Murakami P, Doi A, Lindau P, et al. Comprehensive methylome map of lineage commitment from haematopoietic progenitors. Nature 2010;467:338-342.
30. Carter SL, Cibulskis K, Helman E, McKenna A, Shen H, Zack T, et al. Absolute quantifi cation of somatic DNA alterations in human cancer. Nat Biotechnol 2012;30:413-421.
31. Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK. Unmu-tated Ig V-H genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 1999;94:1848-1854.
32. Dohner H, Stilgenbauer S, Benner A, Leupolt E, Krober A, Bullinger L, et al. Genomic aberrations and survival in chronic lymphocytic leukemia. New Engl J Med 2000;343:1910-1916.
33. Yan H, Parsons DW, Jin GL, McLendon R, Rasheed BA, Yuan WS, et al. IDH1 and IDH2 mutations in gliomas. N Engl J Med 2009; 360: 765-773.
34. Mardis ER, Ding L, Dooling DJ, Larson DE, McLellan MD, Chen K, et al. Recurring mutations found by sequencing an acute myeloid leukemia genome. N Engl J Med 2009;361:1058-1066.
35. Weisenberger DJ, D Siegmund K, Campan M, Young J, Long TI, Faasse MA, et al. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet 2006;38:787-793.
36. Fabris S, Bollati V, Agnelli L, Morabito F, Motta V, Cutrona G, et al. Biological and clinical relevance of quantitative global methylation of repetitive DNA sequences in chronic lymphocytic leukemia. Epige-netics 2011;6:188-194.
37. Hinoue T, Weisenberger DJ, Pan F, Campan M, Kim M, Young J, et al. Analysis of the association between CIMP and BRAF(V600E) in color-ectal cancer by DNA methylation profiling. PLoS ONE 2009;4:e8357.
38. Kröber A, Seiler T, Benner A, Bullinger L, Brückle E, Lichter P, et al. V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia. Blood 2002;100:1410-1416.
39. Bibikova M, Le J, Barnes B, Saedinia-Melnyk S, Zhou LX, Shen R, et al. Genome-wide DNA methylation profi ling using Infi nium (R) assay. Epigenomics 2009;1:177-200.
40. Teschendorff AE, Marabita F, Lechner M, Bartlett T, Tegner J, Gomez-Cabrero D, et al. A beta-mixture quantile normalization method for correcting probe design bias in Illumina Infi nium 450 k DNA meth-ylation data. Bioinformatics 2013;29:189-196.
41. Assenov Y, Muller F, Lutsik P, Walter J, Lengauer T, Bock C. Comprehensive analysis of DNA methylation data with RnBeads. 2013. Available from: http://rnbeads.mpi-inf.mpg.de. Accessed February 1, 2013.
42. Liu YP, Siegmund KD, Laird PW, Berman BP. Bis-SNP: combined DNA methylation and SNP calling for Bisulfi te-seq data. Genome Biol 2012;13:R61.
43. Hullein J, Jethwa A, Stolz T, Blume C, Sellner L, Sill M, et al. Next-generation sequencing of cancer consensus genes in lymphoma. Leuk Lymphoma 2013;54:1831-1835.
44. Edelmann J, Holzmann K, Miller F, Winkler D, Buhler A, Zenz T, et al. High-resolution genomic profi ling of chronic lymphocytic leukemia reveals new recurrent genomic alterations. Blood 2012;120: 4783-4794.